eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	BELLUS Health Inc
Proposed Ticker	BLU
CUSIP	07987C204
Business Description	A clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders.The Company’s product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.
Lead Underwriter	N/A
Co-Managers	N/A
Initial Shares	60,000,000
Revised Initial Shares	N/A
Initial Price	$0.95-$0.95
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A